Literature DB >> 8702085

Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study.

T E McAlindon1, D T Felson, Y Zhang, M T Hannan, P Aliabadi, B Weissman, D Rush, P W Wilson, P Jacques.   

Abstract

BACKGROUND: Evidence suggests that pathophysiologic processes in bone are important determinants of outcome in osteoarthritis of the knee. Low intake and low serum levels of vitamin D may compromise favorable responses of bone to osteoarthritis, predisposing patients to progression.
OBJECTIVE: To determine whether dietary intake and serum levels of vitamin D would predict the incidence and progression of osteoarthritis of the knee in participants of the Framingham Study.
DESIGN: Prospective observational study.
SETTING: The Framingham Study. PARTICIPANTS: Participants in the Framingham Heart Study who had knee radiography at examinations 18 (done between 1983 and 1985) and 22 (done between 1992 and 1993) and received interim assessments of vitamin D intake and serum levels. MEASUREMENTS: Intake of vitamin D and serum levels of 25-hydroxyvitamin D, calculated on the basis of dietary habits and supplement use as reported on a questionnaire, were evaluated at examination 20 (1988 to 1989). Knee radiographs were given scores for global severity of osteoarthritis, using a modification of the scale of Kellgren and Lawrence (range, 0 to 4), and for the presence of osteophytes and joint-space narrowing (range, 0 to 3). Covariates measured at examinations 18 and 20 were age, sex, body mass index, weight change, injury, physical activity, health status, bone mineral density, and energy intake.
RESULTS: 556 participants (mean age at baseline +/- SD, 70.3 +/- 4.5 years) had complete assessments. Incident osteoarthritis occurred in 75 knees; progressive osteoarthritis occurred in 62 knees. Serum levels of vitamin D were modestly correlated with vitamin D intake (r = 0.24). Risk for progression increased threefold in participants in the middle and lower tertiles for both vitamin D intake (odds ratio for the lower compared with the upper tertile, 4.0 [95% Cl, 1.4 to 11.6]) and serum levels of vitamin D (odds ratio for the lower compared with the upper tertile, 2.9[Cl, 1.0 to 8.2]). Low serum levels of vitamin D also predicted loss of cartilage, as assessed by loss of joint space (odds ratio, 2.3 [Cl, 0.9 to 5.5]) and osteophyte growth (odds ratio, 3.1 [Cl, 1.3 to 7.5]). Incident osteoarthritis of the knee occurring after baseline was not consistently related to either intake or serum levels of vitamin D.
CONCLUSIONS: Low intake and low serum levels of vitamin D each appear to be associated with an increased risk for progression of osteoarthritis of the knee.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702085     DOI: 10.7326/0003-4819-125-5-199609010-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  96 in total

Review 1.  Nonpharmacologic therapy of osteoarthritis.

Authors:  P J Perkins; M Doherty
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  Recent advances: rheumatology.

Authors:  R Madhok; H Kerr; H A Capell
Journal:  BMJ       Date:  2000-10-07

3.  Determinants of vitamin D status among overweight and obese Puerto Rican adults.

Authors:  Cristina Palacios; Karen Gil; Cynthia M Pérez; Kaumudi Joshipura
Journal:  Ann Nutr Metab       Date:  2012-01-04       Impact factor: 3.374

4.  Cross-sectional DXA and MR measures of tibial periarticular bone associate with radiographic knee osteoarthritis severity.

Authors:  G H Lo; A M Tassinari; J B Driban; L L Price; E Schneider; S Majumdar; T E McAlindon
Journal:  Osteoarthritis Cartilage       Date:  2012-03-16       Impact factor: 6.576

Review 5.  Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes.

Authors:  Asma Arabi; Rola El Rassi; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

Review 6.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

7.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.

Authors:  Rowan T Chlebowski; Karen C Johnson; Dorothy Lane; Mary Pettinger; Charles L Kooperberg; Jean Wactawski-Wende; Tom Rohan; Mary Jo O'Sullivan; Shagufta Yasmeen; Robert A Hiatt; James M Shikany; Mara Vitolins; Janu Khandekar; F Allan Hubbell
Journal:  Maturitas       Date:  2010-11-18       Impact factor: 4.342

8.  CORR Insights ®: Does vitamin D improve osteoarthritis of the knee: a randomized controlled pilot trial.

Authors:  David T Felson
Journal:  Clin Orthop Relat Res       Date:  2013-09-07       Impact factor: 4.176

9.  Effect of a blend of comfrey root extract (Symphytum officinale L.) and tannic acid creams in the treatment of osteoarthritis of the knee: randomized, placebo-controlled, double-blind, multiclinical trials.

Authors:  Doug B Smith; Bert H Jacobson
Journal:  J Chiropr Med       Date:  2011-07-22

Review 10.  Benefit-risk assessment of vitamin D supplementation.

Authors:  H A Bischoff-Ferrari; A Shao; B Dawson-Hughes; J Hathcock; E Giovannucci; W C Willett
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.